Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Bone Loss and High Bone Turnover in Patients with Non-Hodgkin's Lymphoma Who Receive Frontline Chemotherapy: Final Results of a Multicenter Prospective Study

Evangelos Terpos, MD PhD, Despina Fotiou, MD, Konstantinos Anargyrou, MD, Theodoros P. Vassilakopoulos, MD PhD, Dimitrios Christoulas, MD, Polyzois Makras, MD PhD, Maria Dimou, MD PhD, Ioannis Ntanasis-Stathopoulos, MD, Stavroula Masouridou, MD, Maria K. Angelopoulou, MD, Athanasios Papatheodorou, PhD, Konstantinos Tsionos, MD, Panayiotis Panayiotidis, MD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 4124.

https://doi.org/10.1182/blood-2019-123615

Published: 2019

Journal Articles

Consolidation with Carfilzomib, Lenalidomide and Dexamethasone (KRd) Following ASCT Results in High Rates of Minimal Residual Disease Negativity and Improves Bone Metabolism, in the Absence of Bisphosphonates, Among Newly Diagnosed Patients with Multiple Myeloma

Maria Gavriatopoulou, MD, Evangelos Terpos, MD PhD, Ioannis Ntanasis-Stathopoulos, MD, Panagiotis Malandrakis, MD, Evangelos Eleutherakis-Papaiakovou, MD, Athanasios Papatheodorou, PhD, Nikolaos Kanellias, MD, Magdalini Migkou, MD, Despina Fotiou, MD, Ioanna Dialoupi, MD, Maria Roussou, MD, Nikoletta-Aikaterini Kokkali, Eftathios Kastritis, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 3118.

https://doi.org/10.1182/blood-2019-123916

Published: 2019

Journal Articles

The Role of RANKL/Osteoprotegerin and Wnt Signaling Pathways in the Development of Osteoporosis in Patients with Hemophilia

Panagiotis Anagnostis, Sofia Vakalopoulou, Dimitrios Christoulas, Spyridon Karras, Athanasios Papatheodorou, Eirini Katodritou, Panagiotis Kokkoris, Vasilia Garipidou, Evangelos Terpos

Blood (2015) 126 (23): 2284.

https://doi.org/10.1182/blood.V126.23.2284.2284

Published: 2015

Journal Articles

The CKD-EPI-Cystatin C Equation For The Estimation Of Glomerular Filtration Rate Detects Higher Number Of Patients With Thalassemia Major and Renal Impairment, Before and After Treatment With Deferasirox; Is It Time To Change From MDRD To CKD-EPI-Cystatin C equation In Thalassemia?

Ersi Voskaridou, Dimitrios Christoulas, Athanasios Papatheodorou, Panagiotis Oikonomopoulos, Veroniki Komninaka, Konstantina Repa, Evangelos Terpos

Blood (2013) 122 (21): 3451.

https://doi.org/10.1182/blood.V122.21.3451.3451

Published: 2013

Journal Articles

Vascular Cell Adhesion Molecule-1 Is An Independent Prognostic Factor For Newly-Diagnosed Patients With Multiple Myeloma; Reductions Post VD and Rd In Myeloma Patients At First Relapse

Evangelos Terpos, Magdalini Migkou, Dimitrios Christoulas, Athanasios Papatheodorou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Efstathios Kastritis, Meletios A. Dimopoulos, MD

Blood (2013) 122 (21): 1916.

https://doi.org/10.1182/blood.V122.21.1916.1916

Published: 2013

Journal Articles

Circulating Periostin Is Elevated In Patients With Hemoglobinopathies and Correlates With Bone Mineral Density In Double Heterozygous Sickle-Cell/Beta-Thalassemia Patients; A Novel Marker Of Bone Strength?

Ersi Voskaridou, Dimitrios Christoulas, Athanasios Papatheodorou, Panagiotis Oikonomopoulos, Veroniki Komninaka, Konstantina Repa, Evangelos Terpos

Blood (2013) 122 (21): 3445.

https://doi.org/10.1182/blood.V122.21.3445.3445

Published: 2013

Journal Articles

Semaphorin-4D and Plexin-B1 Are Elevated in Multiple Myeloma Microenvironment and Possibly Contribute in the Development of Lytic Bone Disease

Evangelos Terpos, Efstathios Kastritis, Tina Bagratuni, Dimitrios Christoulas, Athanasios Papatheodorou, Nikolaos Kanellias, Maria Gkotzamanidou, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Meletios A Dimopoulos, MD

Blood (2012) 120 (21): 1819.

https://doi.org/10.1182/blood.V120.21.1819.1819

Published: 2012

Journal Articles

Circulating Activin-A Is Elevated in Patients with Thalassemia Major and Double Heterozygous Sickle-Cell/Beta-Thalassemia and Correlates with Markers of Hemolysis and Bone Mineral Density

Ersi Voskaridou, Dimitrios Christoulas, Maria Dimopoulou, Veroniki Komninaka, Maria Tsalkani, Athanasios Papatheodorou, Evangelos Terpos

Blood (2012) 120 (21): 3256.

https://doi.org/10.1182/blood.V120.21.3256.3256

Published: 2012

Journal Articles

High C-Terminal Cross-Linking Telopeptide of Collagen Type-I (CTX) Predicts for Poor Overall Survival in Patients with Multiple Myeloma Who Receive Frontline Therapy with Immunomodulatory Drugs (IMiDs) but Not with Bortezomib-Based Regimens

Evangelos Terpos, Dimitrios Christoulas, Efstathios Kastritis, Athanasios Papatheodorou, Nikolaos Kanellias, Magdalini Migkou, Maria Gavriatopoulou, Maria Gkotzamanidou, Evangelos Eleutherakis-Papaiakovou, Lia A Moulopoulos, Meletios A Dimopoulos, MD

Blood (2012) 120 (21): 935.

https://doi.org/10.1182/blood.V120.21.935.935

Published: 2012

Journal Articles

High Levels of Periostin in Patients with Multiple Myeloma Correlate with Low Bone Formation, Increased Fracture Rate and Diffuse MRI Pattern; Implications Into the Biology of Myeloma Bone Disease

Evangelos Terpos, Dimitrios Christoulas, Tina Bagratuni, Athanasios Papatheodorou, Maria Gkotzamanidou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Christina Liakou, Lia A Moulopoulos, Efstathios Kastritis, Meletios A Dimopoulos, MD

Blood (2012) 120 (21): 3967.

https://doi.org/10.1182/blood.V120.21.3967.3967

Published: 2012

Journal Articles

The Role of Angiopoietins System in Waldenstrom's Macroglobulinemia: Correlations with Marrow Microvessel Density and Survival

Efstathios Kastritis, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Dimitrios Christoulas, Athanasios Papatheodorou, Maria Gkotzamanidou, Meletios A Dimopoulos, MD, Evangelos Terpos

Blood (2012) 120 (21): 3901.

https://doi.org/10.1182/blood.V120.21.3901.3901

Published: 2012

Journal Articles

Circulating Periostin Is Elevated in Patients with Multiple Myeloma and Correlates with Advanced Disease Features and High Bone Resorption,

Evangelos Terpos, Dimitrios Christoulas, Maria Gkotzamanidou, Evangelos Eleutherakis-Papaiakovou, Athanasios Papatheodorou, Anastasia Pouli, Efstathios Kastritis, Meletios Athanasios Dimopoulos, MD

Blood (2011) 118 (21): 3922.

https://doi.org/10.1182/blood.V118.21.3922.3922

Published: 2011

Journal Articles

Bone Involvement in Patients with Non-Neuronopathic Gaucher Disease Is Characterized by Increased Osteoclast Function Partially Due to High Circulating C-C Motif Ligand 3,

Veroniki Komninaka, Theodore Marinakis, Dimitrios Christoulas, Konstantina Repa, Dionysia Kolomodi, Maria Mitropoulou, Maria Gkotzamanidou, Athanasios Papatheodorou, Nikolaos Anagnostopoulos, Meletios Athanasios Dimopoulos, MD, Evangelos Terpos

Blood (2011) 118 (21): 3215.

https://doi.org/10.1182/blood.V118.21.3215.3215

Published: 2011

Journal Articles

Circulating Angiogenic Cytokines Are Elevated in Patients with Smoldering Myeloma; Implications Into Disease Biology

Maria Gkotzamanidou, Evangelos Terpos, Athanasios Papatheodorou, Evangelos Eleutherakis-Papaiakovou, Meletios Athanasios Dimopoulos, MD, Efstathios Kastritis

Blood (2011) 118 (21): 5059.

https://doi.org/10.1182/blood.V118.21.5059.5059

Published: 2011

Journal Articles

Circulating Levels of the Wnt Inhibitors Dickkopf-1 and Sclerostin In Different Phases of Multiple Myeloma: Alterations Post-Therapy with Lenalidomide and Dexamethasone with or without Bortezomib

Evangelos Terpos, Dimitrios Christoulas, Maria Gkotzamanidou, Cornelia Bratengeier, Maria Gavriatopoulou, Magdalini Migkou, Athanasios Papatheodorou, Efstathios Kastritis, Wolfgang Woloszczuk, Meletios A. Dimopoulos

Blood (2010) 116 (21): 2963.

https://doi.org/10.1182/blood.V116.21.2963.2963

Published: 2010

Journal Articles

Elevated Levels of Circulating Activin-A Correlate with Features of Advanced Disease, Extensive Bone Involvement and Inferior Survival In Patients with Multiple Myeloma

Evangelos Terpos, Dimitrios Christoulas, Efstathios Kastritis, Maria Gkotzamanidou, Maria Gavriatopoulou, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, Maria Roussou, Athanasios Papatheodorou, Meletios A. Dimopoulos

Blood (2010) 116 (21): 2967.

https://doi.org/10.1182/blood.V116.21.2967.2967

Published: 2010

Journal Articles

Low Bone Mineral Density and High Bone Turnover In Patients with Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study

Konstantinos Anargyrou, Theodoros P. Vassilakopoulos, Konstantinos Tsionos, Panayiotis Kokkoris, Georgios Boutsikas, Maria K. Angelopoulou, Dimitrios Christoulas, Stavroula Masouridou, Maria Dimou, Athanasios Papatheodorou, Danos N. Chatzifotiadis, Panayiotis Panayiotidis, Gerasimos A. Pangalis, Photis Beris, Evangelos Terpos

Blood (2010) 116 (21): 5071.

https://doi.org/10.1182/blood.V116.21.5071.5071

Published: 2010

Journal Articles

High Circulating Levels of Sclerostin Correlate with Bone Mineral Density In Patients with Thalassemia and Osteoporosis: The Role of the Wnt Signaling In the Pathogenesis of Bone Loss In Thalassemia

Ersi Voskaridou, Dimitrios Christoulas, Athanasios Papatheodorou, Cornelia Bratengeier, Eleni Plata, Despoina Kaliontzi, Wolfgang Woloszczuk, Evangelos Terpos

Blood (2010) 116 (21): 1010.

https://doi.org/10.1182/blood.V116.21.1010.1010

Published: 2010

Journal Articles

The Addition of Bortezomib to the Combination of Lenalidomide and Dexamethasone Increases Bone Formation in Relapsed/Refractory Myeloma: a Prospective Study in 91 Patients.

Evangelos Terpos, Dimitrios Christoulas, Efstathios Kastritis, Maria Roussou, Maria Gavriatopoulou, Magdalini Migkou, Maria Gkotzamanidou, Marina Iakovaki, Athanasios Papatheodorou, Meletios A. Dimopoulos

Blood (2009) 114 (22): 1815.

https://doi.org/10.1182/blood.V114.22.1815.1815

Published: 2009

Journal Articles

Increased levels of Vascular Cell Adhesion Molecule-1 (VCAM-1) and Inter-Cellular Adhesion Molecule-1 (ICAM-1) Correlate with Advanced Disease Features and Poor Survival in Newly Diagnosed Patients with Multiple Myeloma. Reduction Post-Bortezomib- and Lenalidomide-Based Regimens.

Magdalini Migkou, Evangelos Terpos, Dimitrios Christoulas, Maria Gavriatopoulou, Georgios Boutsikas, Maria Gkotzamanidou, Marina Iakovaki, Efstathios Kastritis, Athanasios Papatheodorou, Meletios A. Dimopoulos

Blood (2009) 114 (22): 1824.

https://doi.org/10.1182/blood.V114.22.1824.1824

Published: 2009

NARROW

Bone Loss and High Bone Turnover in Patients with Non-Hodgkin's Lymphoma Who Receive Frontline Chemotherapy: Final Results of a Multicenter Prospective Study

Consolidation with Carfilzomib, Lenalidomide and Dexamethasone (KRd) Following ASCT Results in High Rates of Minimal Residual Disease Negativity and Improves Bone Metabolism, in the Absence of Bisphosphonates, Among Newly Diagnosed Patients with Multiple Myeloma

The Role of RANKL/Osteoprotegerin and Wnt Signaling Pathways in the Development of Osteoporosis in Patients with Hemophilia

The CKD-EPI-Cystatin C Equation For The Estimation Of Glomerular Filtration Rate Detects Higher Number Of Patients With Thalassemia Major and Renal Impairment, Before and After Treatment With Deferasirox; Is It Time To Change From MDRD To CKD-EPI-Cystatin C equation In Thalassemia?

Vascular Cell Adhesion Molecule-1 Is An Independent Prognostic Factor For Newly-Diagnosed Patients With Multiple Myeloma; Reductions Post VD and Rd In Myeloma Patients At First Relapse

Circulating Periostin Is Elevated In Patients With Hemoglobinopathies and Correlates With Bone Mineral Density In Double Heterozygous Sickle-Cell/Beta-Thalassemia Patients; A Novel Marker Of Bone Strength?

Semaphorin-4D and Plexin-B1 Are Elevated in Multiple Myeloma Microenvironment and Possibly Contribute in the Development of Lytic Bone Disease

Circulating Activin-A Is Elevated in Patients with Thalassemia Major and Double Heterozygous Sickle-Cell/Beta-Thalassemia and Correlates with Markers of Hemolysis and Bone Mineral Density

High C-Terminal Cross-Linking Telopeptide of Collagen Type-I (CTX) Predicts for Poor Overall Survival in Patients with Multiple Myeloma Who Receive Frontline Therapy with Immunomodulatory Drugs (IMiDs) but Not with Bortezomib-Based Regimens

High Levels of Periostin in Patients with Multiple Myeloma Correlate with Low Bone Formation, Increased Fracture Rate and Diffuse MRI Pattern; Implications Into the Biology of Myeloma Bone Disease

The Role of Angiopoietins System in Waldenstrom's Macroglobulinemia: Correlations with Marrow Microvessel Density and Survival

Circulating Periostin Is Elevated in Patients with Multiple Myeloma and Correlates with Advanced Disease Features and High Bone Resorption,

Bone Involvement in Patients with Non-Neuronopathic Gaucher Disease Is Characterized by Increased Osteoclast Function Partially Due to High Circulating C-C Motif Ligand 3,

Circulating Angiogenic Cytokines Are Elevated in Patients with Smoldering Myeloma; Implications Into Disease Biology

Circulating Levels of the Wnt Inhibitors Dickkopf-1 and Sclerostin In Different Phases of Multiple Myeloma: Alterations Post-Therapy with Lenalidomide and Dexamethasone with or without Bortezomib

Elevated Levels of Circulating Activin-A Correlate with Features of Advanced Disease, Extensive Bone Involvement and Inferior Survival In Patients with Multiple Myeloma

Low Bone Mineral Density and High Bone Turnover In Patients with Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study

High Circulating Levels of Sclerostin Correlate with Bone Mineral Density In Patients with Thalassemia and Osteoporosis: The Role of the Wnt Signaling In the Pathogenesis of Bone Loss In Thalassemia

The Addition of Bortezomib to the Combination of Lenalidomide and Dexamethasone Increases Bone Formation in Relapsed/Refractory Myeloma: a Prospective Study in 91 Patients.

Increased levels of Vascular Cell Adhesion Molecule-1 (VCAM-1) and Inter-Cellular Adhesion Molecule-1 (ICAM-1) Correlate with Advanced Disease Features and Poor Survival in Newly Diagnosed Patients with Multiple Myeloma. Reduction Post-Bortezomib- and Lenalidomide-Based Regimens.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only